These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5011667)

  • 1. The causes of abnormal pulmonary function in Parkinson's disease.
    Obenour WH; Stevens PM; Cohen AA; McCutchen JJ
    Am Rev Respir Dis; 1972 Mar; 105(3):382-7. PubMed ID: 5011667
    [No Abstract]   [Full Text] [Related]  

  • 2. Levodopa in Parkinson's disease: effect on pulmonary function.
    Nakano KK; Bass H; Tyler HR
    Arch Intern Med; 1972 Sep; 130(3):346-8. PubMed ID: 4560177
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in pulmonary function in Parkinson's syndrome after treatment with L-DOPA.
    Langer H; Woolf CR
    Am Rev Respir Dis; 1971 Sep; 104(3):440-2. PubMed ID: 5098678
    [No Abstract]   [Full Text] [Related]  

  • 4. Some "minor" aspects of parkinsonism, especially pulmonary function.
    Paulson GD; Tafrate RH
    Neurology; 1970 Dec; 20(12):Suppl:14-7. PubMed ID: 5529912
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary function in chronic alcoholism.
    Banner AS
    Am Rev Respir Dis; 1973 Oct; 108(4):851-7. PubMed ID: 4741879
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal ventilatory control in Parkinson's disease--further evidence for non-motor dysfunction.
    Seccombe LM; Giddings HL; Rogers PG; Corbett AJ; Hayes MW; Peters MJ; Veitch EM
    Respir Physiol Neurobiol; 2011 Dec; 179(2-3):300-4. PubMed ID: 21982817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of psychometic tests in 23 patients with Parkinson's disease after 6 months treatment with L-dopa].
    Barbizet J; Duizabo P; Pasquier M
    Rev Neurol (Paris); 1972 Aug; 127(2):311-3. PubMed ID: 4666638
    [No Abstract]   [Full Text] [Related]  

  • 8. Some "minor" aspects of parkinsonism, especially pulmonary function.
    Paulson GD; Tafrate RH
    Neurology; 1970 Dec; 20(12):14-7. PubMed ID: 5531290
    [No Abstract]   [Full Text] [Related]  

  • 9. Upper airway muscles dysfunction and levodopa responsiveness in Parkinson's disease.
    Brescia Morra V; Polverino M; De Luca G; Landi P; Galdi A; Campanella G
    Acta Neurol (Napoli); 1992; 14(4-6):512-8. PubMed ID: 1293993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in the management of Parkinson's disease.
    Chapman WG
    West Indian Med J; 1974 Mar; 23(1):61-4. PubMed ID: 4456821
    [No Abstract]   [Full Text] [Related]  

  • 11. Oculomotor dysfunction in Parkinson's disease.
    Corin MS; Elizan TS; Siegel GJ
    Trans Am Neurol Assoc; 1970; 95():226-9. PubMed ID: 5514375
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease.
    Van Woert MH
    Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoconsistency in ventilatory mechanics.
    Vezzoli F; Pelosi V; Mignone V; Marazzini L; Longhini E
    Respiration; 1974; 31(3):221-39. PubMed ID: 4836684
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neurogenic bladder disturbances in Parkinson's disease (author's transl)].
    Schneider E; Patras L; Fischer PA
    Fortschr Neurol Psychiatr Grenzgeb; 1978 May; 46(5):260-8. PubMed ID: 248041
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification of respiratory function parameters in patients with severe Parkinson's disease.
    De Pandis MF; Starace A; Stefanelli F; Marruzzo P; Meoli I; De Simone G; Prati R; Stocchi F
    Neurol Sci; 2002 Sep; 23 Suppl 2():S69-70. PubMed ID: 12548348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
    Sano I; Taniguchi K
    Munch Med Wochenschr; 1972 Oct; 114(40):1717-9. PubMed ID: 4538893
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease and impaired chemosensitivity to hypoxia.
    Röggla G; Weber W; Röggla M
    Lancet; 2000 Dec; 356(9247):2099. PubMed ID: 11145518
    [No Abstract]   [Full Text] [Related]  

  • 18. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
    Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K
    Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric disturbances in Parkinson's disease.
    Celesia GG; Wanamaker WM
    Dis Nerv Syst; 1972 Sep; 33(9):577-83. PubMed ID: 4649149
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired potentiation of H-reflexes in patients with Parkinson's disease.
    Sica RE; Aguilera N; Herskovits E
    Medicina (B Aires); 1972; 32(6):588-95. PubMed ID: 4663253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.